Key Benefits Of PCR-Based mRNA Manufacturing For Clinical Development

Unlock the potential of your mRNA therapies and accelerate your mRNA development and manufacturing program with a novel PCR-based mRNA drug substance manufacturing process. This innovative and flexible process enables the provision of mRNA at all scales and qualities for all stages of a mRNA program life cycle, from pre-clinical to commercial.

Explore the advantages of a truly integrated mRNA-LNP CDMO solution and discover how MilliporeSigma can serve as your single-source partner along all critical steps from mRNA drug substance manufacturing through to the fill and finish of the final drug product.